BASSANI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 414
EU - Europa 209
AS - Asia 208
SA - Sud America 6
AF - Africa 4
OC - Oceania 1
Totale 842
Nazione #
US - Stati Uniti d'America 414
IT - Italia 96
CN - Cina 86
SG - Singapore 76
RU - Federazione Russa 20
FR - Francia 19
FI - Finlandia 18
DE - Germania 11
IN - India 11
GB - Regno Unito 10
CH - Svizzera 9
JP - Giappone 8
ES - Italia 6
KR - Corea 6
PK - Pakistan 6
BR - Brasile 4
IE - Irlanda 4
IR - Iran 4
CZ - Repubblica Ceca 3
HK - Hong Kong 3
NL - Olanda 3
PL - Polonia 3
TW - Taiwan 3
UA - Ucraina 3
AR - Argentina 2
BD - Bangladesh 2
EG - Egitto 2
NG - Nigeria 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
DK - Danimarca 1
ID - Indonesia 1
SE - Svezia 1
TH - Thailandia 1
Totale 842
Città #
Santa Clara 71
Singapore 60
Chandler 39
Ashburn 33
Padova 32
Boardman 27
Columbus 26
Beijing 25
Fairfield 19
Ogden 17
Helsinki 16
Houston 8
Milan 7
Phoenix 7
Seattle 7
Barcelona 6
Cambridge 6
Basel 5
Camerino 5
Medford 5
Princeton 5
Wilmington 5
Woodbridge 5
Cagliari 4
Los Angeles 4
Rome 4
Tehran 4
Chicago 3
Des Moines 3
Reggio Calabria 3
Roxbury 3
San Casciano in Val di Pesa 3
San Diego 3
Warsaw 3
Affoltern am Albis 2
Ahmedabad 2
Amsterdam 2
Ancona 2
Bengaluru 2
Brogliano 2
Clifton 2
Concorezzo 2
Cordoba 2
Cosenza 2
Dublin 2
Gorgonzola 2
Guangzhou 2
Karachi 2
Kasama 2
Kolkata 2
Kumamoto 2
Kyiv 2
Lagos 2
Lappeenranta 2
Liaocheng 2
Limena 2
London 2
Newton-le-Willows 2
Paris 2
Prescot 2
Rio de Janeiro 2
Seodaemun-gu 2
Taglio 2
Taipei 2
Tanta 2
Tukwila 2
Ulhasnagar 2
West Jordan 2
Zurich 2
Aarhus 1
Aligarh 1
Americana 1
Bangkok 1
Bologna 1
Bolzano 1
Brno 1
Cittadella 1
Council Bluffs 1
Dhaka 1
Fontanelle 1
Gainesville 1
Gmunden 1
Gunzenhausen 1
Gwanak-gu 1
Hamburg 1
Hohenlinden 1
Hradec Králové 1
Hyderabad 1
Inzai 1
Jakarta 1
Khulna 1
Lahore 1
Las Vegas 1
Luohe 1
Lviv 1
Manchester 1
Montecrestese 1
Montegrotto Terme 1
Moscow 1
Multan 1
Totale 574
Nome #
“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies 79
Application, evaluation, and improvement of computational methodologies in drug discovery 67
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation 65
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1 delta 63
Inspecting the Mechanism of Fragment Hits Binding on SARS‐CoV‐2 M pro by Using Supervised Molecular Dynamics (SuMD) Simulations 53
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332 50
Omicron Variant of SARS-CoV-2 Virus: In Silico Evaluation of the Possible Impact on People Affected by Diabetes Mellitus 42
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease Mpro 40
Qualitative Estimation of Protein-Ligand Complex Stability through Thermal Titration Molecular Dynamics Simulations 34
In silico evaluation of the interaction between ACE2 and SARS-CoV-2 Spike protein in a hyperglycemic environment 30
From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19? 30
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma 29
Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study 28
Sodium or Not Sodium: Should Its Presence Affect the Accuracy of Pose Prediction in Docking {GPCR} Antagonists? 28
SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376 28
Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism? 27
Computational Strategies to Identify New Drug Candidates against Neuroinflammation 27
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)? 25
Investigating RNA-protein recognition mechanisms through supervised molecular dynamics (SuMD) simulations 25
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective? 24
Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants 23
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors 12
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma 10
7-Amino-[1,2,4]triazolo[1,5-a][1,3,5]triazines as CK1δ inhibitors: Exploring substitutions at the 2 and 5-positions 10
Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies 10
A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system 4
Totale 863
Categoria #
all - tutte 6.580
article - articoli 6.375
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.955


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202285 0 0 0 0 0 0 19 7 39 2 3 15
2022/2023154 13 0 1 8 19 16 2 32 22 17 21 3
2023/2024320 12 27 53 24 39 22 48 24 30 9 13 19
2024/2025304 16 47 48 36 113 42 2 0 0 0 0 0
Totale 863